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Objectives. The purpose of this study was to identify the clinical
characteristics of family members at risk of sudden death.
Background. The significance of sudden death in heritable
cardiac disorders with delayed expression is incompletely under-
stood. Additional insights come from a four-decade experience of
seven generations of a family of German origin with autosomal
dominant (chromosome 1p1-1q1) cardiac conduction and myocar-
dial disease.
Methods and Results. A total of 38 family members (20 males; 18
females) were identified with sudden death. Twenty-eight family
members (mean age 48 6 8 years) from earlier generations had no
pacemaker at the time of sudden death. In this group, 15 subjects
were asymptomatic prior to sudden death. Ten family members
with sudden death, from later generations, had chronically im-
planted pacemakers for high grade atrioventricular block. This
group was older (mean age 57 6 2 years), with decreased
functional status (New York Heart Association class II to IV),
enlarged left atria, dilated left ventricles with reduced systolic
function and documented ventricular fibrillation in three mem-
bers. Twenty-eight family members with sudden death were de-
scendants of sib lineages 2 or 6; 21 family members with sudden
death were offspring of a parent who also suffered sudden death.
Conclusion. Sudden death is an important late outcome in
heritable (chromosome 1p1-1q1) cardiac conduction and myocar-
dial disease. Pacemaker therapy is important for the treatment of
symptomatic bradycardia, but it does not prevent sudden death.
Family members who are beyond the third decade of life with
reduced functional capacity, left ventricular dysfunction, pace-
makers and who are the offspring of a parent with sudden death
appear to be at greatest risk.
(J Am Coll Cardiol 1998;32:1717–23)
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With recent advances in molecular genetics, heritable disor-
ders of the cardiovascular system are emerging as an important
cause of cardiovascular disease in adults (1–14). The clinical
significance of sudden death in heritable cardiac disorders is
incompletely understood. The identification of heritable syn-
dromes, which have delayed expression, requires the develop-
ment of multigenerational pedigrees. We have had the unique
opportunity to engage in a multigenerational study of an
autosomal dominant heritable cardiac disorder with a genetic
defect located on chromosome (1p1-1q1) (15). Our initial
report of this syndrome in 1986 characterized affected family
members as having progressive development of cardiac con-
duction abnormalities, which precede the development of
myocardial dysfunction (16). Late affected family members
eventually require permanent pacemakers for symptomatic
complete heart block and asystole in the setting of chronic
atrial fibrillation. Initially, sudden death did not appear to be
an important feature of this disorder. As we have expanded our
study, a greater number of family members have been identi-
fied with sudden death syndrome. The purpose of this study
was to determine the clinical characteristics of affected family
members with sudden death.
Methods
Both pedigree information and clinical history were ob-
tained in 479 family members over seven generations. All
studies were performed after obtaining human subjects review
consent. In addition, 239 of the family members have had an
assessment of left ventricle function (by echocardiography or
nuclear studies) and electrocardiographic monitoring. Echo-
cardiographic studies were performed by standard techniques
using a Hewlett-Packard Sonos 1000 (Andover, Massachu-
setts). Standard echocardiographic measurements were made
according to the recommendations of the American Society of
Echocardiography. Presence of ventricular or atrial tachyar-
rhythmias was confirmed either by 12-lead electrocardiogra-
phy, ambulatory monitoring or telemetry monitoring. Conges-
tive heart failure was defined as the presence of the clinical
signs of rales, peripheral edema and increased jugular venous
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pressure. Between 1977 and 1994, selected family members
underwent invasive programmed ventricular stimulation stud-
ies employing percutaneously introduced multipolar pacing
catheters positioned in the appropriate chambers. Standard
stimulation protocols were employed for the induction of
ventricular tachycardia.
Sudden death was defined as death occurring within min-
utes after symptom onset, or during sleep, and was considered
to be due to the familial disease in the absence of other
recognizable causes. The account of the sudden death event
was usually obtained from family members closest to the victim
and corroborated in some instances by family lineage records
or from public records. Six of the recent sudden death victims
had detailed cardiac evaluation from autopsy.
Multigenerational pedigrees for sib lineages are presented
in Figures 1 to 4. Each family member is referenced by a
three-part confidential code with respect to sib, generation and
number within a generation. The number order of siblings
within a generation was altered to protect confidentiality.
Females are represented as circles and males as squares.
Sudden death victims are denoted as solid symbols and an S.
An arrow identifies family members with sudden death who
have had autopsies.
Statistical analysis. Data are presented as the mean 6 SD.
Data between groups were compared with nonparametric
methods (Mann–Whitney). A p value ,0.05 was considered
significant.
Results
Thirty-eight family members (20 males, 18 females) were
identified with sudden death associated with heritable conduc-
tion and myocardial disease (Fig. 5). Generation V was a
transition period when pacemaker therapy became increas-
ingly available. The overall incidence of sudden death is 13.7%
in the sample of family members enrolled in our study. The
mean age at sudden death was 51 6 8 years.
Three family members died suddenly while sedentary, 6
experienced sudden death during sleep and 24 had sudden
death during physical activity. The activity level was uncertain
at the time of sudden death in five victims. Five sudden death
victims were taking oral sodium channel blockers. Twenty-
eight family members did not have a pacemaker (group A),
whereas 10 family members did have a pacemaker (group B) at
the time of sudden death.
Group A consisted primarily of family members from
earlier generations before pacemaker therapy became wide-
spread. There were 15 females and 13 males, with a mean age
of 48 6 8 years. Clinical characteristics of group A family
members are less detailed because they were from earlier
generations. Fifteen were asymptomatic prior to sudden death;
nine family members had some history of cardiovascular
disease (seven with palpitations, one had heart failure and one
had heart failure and previous strokes). Clinical history was
unknown in four family members.
Group B family members (pacemaker group; six males and
four females; mean age 57 6 2 years) were from later
generations when pacemaker therapy was available. All group
B family members also had evidence of cardiomyopathy, high
grade atrioventricular (AV) block and evidence of reduced
functional capacity (New York Heart Association [NYHA]
Functional Classifications ranging from class II to class IV). All
appeared to have normal pacemaker function at the time of
Abbreviations and Acronyms
NYHA 5 New York Heart Association
PVS 5 programmed ventricular stimulation
VT 5 ventricular tachycardia
Figure 1. Multigenerational pedigree for sib 2. Each family member is
referenced by a confidential code as described in the Methods section.
Females are represented as circles and males as squares. Sudden
death victims are denoted with a filled symbol and an S. Family
members with autopsies are identified with an arrow.
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sudden death. In three family members, ventricular fibrillation
was documented at the time of sudden death.
Multigenerational pedigrees. Multigenerational pedigrees
allowed us to study patterns of sudden death within the family
lineage. The lineages from sib 2 and sib 6 are the most
complete. Less information is available on the pedigrees for
sibs 5, 7 and 9.
A total of 14 (12%) sudden death events have occurred in
117 descendants of sibling 2, who was also a victim of sudden
death. Thirteen of the 14 sudden death events occurred in
family members from Generations IV and V (Fig. 1). Thirteen
(18%) sudden death events have been recorded in 73 descen-
dants from sib 6 (Fig. 2). There was some clustering of sudden
death events. The family member 6-III-3 lineage had three
sudden deaths, and family member 6-III-6 lineage had six
sudden death events.
Seven (14%) sudden deaths occurred in 51 family members
from the sib 5 lineage (Fig. 3). Five of the seven sudden death
victims were descendants of family member 5-III-3, who was
also a victim of sudden death. Less information is known about
the sib 9 lineage. A total of two sudden deaths have been
identified in this lineage, one from Generation IV and one
from Generation V. Twenty-eight family members with sudden
death were descendants of sib 2 or sib 6 (including sib 2, who
also had sudden death). Twenty-one of the 38 victims of
sudden death were offspring of a parent who also had suffered
sudden death.
Figure 2. Multigenerational pedigree for sib 6. See legend for Figure
1 for explanation of pedigree code.
Figure 3. Multigenerational pedigree for sib 5. See legend for Figure
1 for explanation of pedigree code.
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Clinical characteristics of sudden death victims. Studies of
clinical characteristics focused on later generations where
clinical data were more complete. Ten of 11 sudden deaths
recorded since 1974 have occurred in family members with
functioning permanent pacemakers. Chronic pacemaker ther-
apy was required for advanced high grade AV block.
We attempted to determine predictors of sudden death in
affected family members with a pacemaker (group 3; n 5 10)
by comparing them to affected family members with pacemak-
ers but without sudden death (group 2; n 5 19) and to affected
family members without pacemakers and without sudden
death (group 1; n 5 30). Clinical, echocardiographic and
electrocardiographic features were compared by nonparamet-
ric analysis.
In comparing groups 2 and 3, no significant difference was
noted between the groups with respect to age, age of onset of
symptoms, age at pacemaker implant or NYHA functional
classification (Table 1). Sudden death victims did tend to have
longer durations of pacemaker therapy than did nonsudden
death victims with pacemakers. Echocardiographic findings
also varied between the groups. Sudden death victims tended
to have larger end diastolic and end systolic chamber diame-
ters, a lower %DD and a larger left atrial size than did the
nonsudden death group with pacemakers. Even though there
was considerable overlap in echocardiographic measurements
between the groups, a %DD less than 19% and a left atrial size
greater than 5.4 cm were more likely to be present in sudden
death victims. Electrocardiographic presence of atrial fibrilla-
tion and nonsustained ventricular tachycardia did not differ
between groups 2 and 3 (Table 1).
Electrophysiologic testing. Between 1977 and 1996, 14
family members (3 with subsequent sudden death; 11 without)
underwent programmed ventricular stimulation (PVS) for the
induction of ventricular tachyarrhythmias (VT). The indication
for PVS was based on clinical symptoms of palpitations, near
syncope or syncope and abnormalities recorded during elec-
trocardiographic monitoring. The family members studied
were scattered throughout the multigenerational pedigree (six
were from the sib 2 lineage; three from sib 6; four from sib 5;
one from sib 7 lineages).
Two of 14 family members had inducible sustained mono-
morphic VT. Both presented with syncope; both had chroni-
cally implanted pacemakers and subsequently underwent im-
plantation of internal defibrillators.
All three of the family members who subsequently died of
sudden death did not have inducible VT at the time of PVS.
One sudden death occurred within 1 year of PVS (triple
extrastimuli protocol), whereas the other two sudden deaths
occurred at 11 and 14 years after PVS (double extrastimuli
protocol). The differences in the number of extrastimuli re-
flects the evolution of electrophysiology testing over the past
two to three decades to include more aggressive stimulation
protocols for the induction of ventricular tachycardia.
Autopsy data. An autopsy was performed on six family
members who had sudden death. Autopsies were performed
between 1987 and 1996. The average age at death was 56 6 7
years. The lineage of sudden death victims who had an autopsy
are indicated by an arrow adjacent to their respective symbol
on the pedigree charts. Four sib 2 and two sib 5 family
members had such data.
All six hearts had significant hypertrophy (mean weight
577.1 6 71.3 g). Five had varying degrees of sinus node fibrosis.
Six hearts had marked AV node fibrosis, with fatty infiltrate in
Figure 4. Multigenerational pedigree for sib 9. See legend for Figure
1 for explanation of pedigree code.
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four. Moderate to severe right and left atrial dilation was ob-
served in five specimens (total of five reported), and moderate
right ventricular enlargement was noted in six. Mild to moderate
left ventricular enlargement was noted in six specimens, and right
and left ventricular hypertrophy was observed in three specimens.
Interstitial fibrosis was observed in all six specimens (patchy in
three, diffuse in three) and involved all chambers of the heart. The
two most recent autopsies showed a unique pattern of fibrosis
involving the middle third of the interventricular septum extend-
ing to the left ventricular posterior wall. There was no evidence of
old or recent myocardial infarction. No significant coronary artery
disease was detected except for a single 75% stenosis of the left
anterior descending coronary artery of questionable significance
in one individual.
Discussion
The role of heredity in adult cardiovascular disease contin-
ues to expand. We have reported in an earlier study the
phenotypic expression of the heritable (chromosome 1p1-1q1)
cardiac conduction and myocardial disease (16). We have
greatly expanded the number of family members enrolled since
the initial report. Sudden death has emerged as an important
outcome in this heritable disorder.
We have identified 38 family members from the multigen-
erational pedigree who have been victims of sudden death.
Family members without pacemakers tended to have earlier
onset of sudden death than did family members who had
Figure 5. Graph showing distribution of family members with sudden
death with respect to generation in the family pedigree and age at
death. Open circles 5 family members without pacemaker. Closed
triangles 5 family members with pacemaker.







(n 5 10) p Value
Age 35.7 6 7.9 58.6 6 9.5 56.5 6 6.3 NS
Symptom onset N/A 35.9 6 11.4 42.4 6 4.3 NS
Age—Pacemaker N/A 52.3 6 10.1 46.5 6 5.9 NS
NYHA FC 1 2.8 6 0.9 3.1 6 0.7 NS
CHF 0% 50% 70% NS
Years of PM therapy N/A 6.2 6 5.3 10.0 6 4.5 0.052
Echocardiography
LVIDd (cm) 5.1 6 0.6 (28) 5.6 6 0.7 (10) 6.3 6 0.3 (6) 0.019
LVIDs (cm) 3.2 6 0.5 (27) 3.9 6 0.8 (9) 4.9 6 0.3 (6) 0.028
LV mass (gm) 122.7 6 28.1 (23) 148 6 30.4 (8) 175 6 18.4 (4) NS
%DD 37.1 6 5.2 (27) 30.4 6 6.9 (9) 20.0 6 2.2 (5) 0.032
LA size (cm) 3.8 6 0.5 (29) 4.2 6 0.6 (9) 5.1 6 1.0 (6) 0.07
Nonsustained VT 0.03% (30) 45% (11) 75% (8) NS
AFIB 0.03% (30) 93% (15) 100% (8) NS
Group 1 (n 5 30) consists of family members without pacemakers or sudden
death; group 2 (n 5 19) consists of those with pacemaker but without sudden
death; group 3 (n 5 10) are those with pacemakers and with sudden death. “Age”
for sudden death group was the age at time of death. AFIB 5 atrial fibrillation;
CHF 5 congestive heart failure; LA size 5 left atrial size; LV mass 5 5 left
ventricular mass; LVIDd 5 end diastolic left ventricular internal diameter;
LVIDs 5 end systolic left ventricular internal diameter; N/A 5 not applicable;
NYHA FC 5 New York Heart Association functional classification; PM 5
pacemaker; VT 5 ventricular tachycardia; %DD 5 percent fractional shorten-
ing. Sample size is included in parentheses for each measurement. The p value
shows nonparametric comparison between groups 2 and 3.
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pacemakers. The reason for this finding may be multifactorial.
Family members without pacemakers were from earlier gen-
erations before pacemaker therapy was widely available. Pace-
maker therapy clearly prevents symptomatic high grade AV
block that occurs in the late phases of disease; however, the
role of pacing in the delay in the onset of sudden death is not
clear. Improvements in medical therapy for the treatment of
congestive heart failure and arrhythmias may also be important
for the improvement in survival observed in later generations.
Even though affected family members with pacemakers tended
to live longer than did family members without pacemakers,
pacemaker therapy did not prevent sudden death in a substan-
tial number of family members with pacemakers. Nearly a third
of family members with pacemakers had sudden death.
Our data suggest that sudden death is a late outcome of
disease progression rather than a heritable propensity for
sudden death independent of cardiomyopathy. Clearly, the
fibrotic myopathy alone may be all that is required for a family
member to be at risk of sudden death. Multigenerational
pedigrees show some patterns in the sudden death events.
Over half the family members with sudden death were direct
descendants of a parent who also had sudden death. In
addition, there was some evidence of clustering of sudden
deaths within certain regions of the pedigree. These data
suggest that multigenerational pedigrees may be of value for
risk stratification of affected family members.
The mechanism of sudden death in this family remains
elusive. Life-threatening bradyarrhythmias may have played a
role in precipitating sudden death in family members from
earlier generations without pacemakers. However, sudden
death in family members from later generations with function-
ing pacemakers suggests that ventricular tachyarrhythmias,
rather than bradyarrhythmias, are important. In fact, three
family members had ventricular fibrillation as the first rhythm
detected at the time of attempted resuscitation. The mecha-
nisms of ventricular tachyarrhythmias in this family remain
unclear. Disorders of repolarization, as detected by QT inter-
val prolongation, have not been a phenotypic expression in
affected family members without pacemakers in the earlier
stages of disease (16). Of course, the use of the QT interval
duration as a marker of abnormal repolarization is uncertain
during ventricular pacing in the later stages of disease. There-
fore, we cannot exclude dispersion of refractoriness or after
depolarizations as potential mechanisms for lethal ventricular
arrhythmias. The presence of ventricular myocardial fibrosis
suggests that reentry may be a possible mechanism of lethal
arrhythmias. The presence of inducible sustained monomor-
phic VT in two family members supports the reentry hypoth-
esis. The value of programmed ventricular stimulation to
identify high risk family members needs further study.
To date, no affected family members have had heart
transplants. Sudden death has usually been an out-of-hospital
event and not in the setting of severe congestive heart failure.
Those family members who advance to class IV congestive
heart failure are usually in the seventh decade of life, beyond
the acceptable cutoff age for cardiac transplant.
Study limitations. Several of the sudden deaths reported in
this study occurred in family members from earlier generations
when cardiac diagnostics were less advanced. However, the
definition of a death as “sudden” depends heavily on witness
accounts. This definition has not changed significantly over the
past several decades. Epstein et al. (17) highlighted some of
the difficulties in sudden death classification, most of which are
as appropriate today as they were decades ago.
It certainly is possible that some of the sudden deaths
reported were due to noncardiac-related disorders or cardiac
diseases unrelated to the heritable chromosome 1p1-1q1 dis-
order. Cardiac catheterization and autopsy data from this
family suggest that the more common cardiac disorders such as
coronary artery disease are not routinely present, increasing
the likelihood that sudden death is due to the underlying
heritable cardiac disorder. As genotype classification becomes
more readily available in this family, some of these ambiguities
will be resolved.
Even though the true incidence of sudden death in the
family cannot be determined with certainty until all family
members are accounted for, the remarkable consistency of
sudden death rates in each sib lineage suggests our data may be
a reasonable approximation. For example, the sib 2 pedigree is
most complete and has a sudden death incidence of 12%. In
contrast, the sib 5 lineage is less complete but still has a sudden
death rate of 14%.
Conclusions. Sudden death emerges as an important out-
come in late affected family members with heritable (chromo-
some 1p1-1q1) cardiac conduction and myocardial disease.
Family members beyond the third decade of life with evidence
of atrial and ventricular myopathy, reduced functional class,
pacemakers and a parent with sudden death appear to be at
highest risk for sudden death. Sudden death occurs despite
pacemaker therapy. The unique pattern of midmyocardial
fibrosis and midseptal fibrosis in sudden death victims may
provide the substrate for predisposition to lethal ventricular
tachyarrhythmias. Prophylactic implantable defibrillators may
be warranted in high risk family members.
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